Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CS-3150

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BACKGROUND AND OBJECTIVES The progression of kidney disease in some patients with type 2 diabetes mellitus may not be adequately… Expand
Is this relevant?
2019
2019
Mineralocorticoid receptors (MRs) are implicated in the pathology of hypertension. MR blockers are recommended for the treatment… Expand
Is this relevant?
2019
2019
Although beneficial antihypertensive and antialbuminuric effects of steroidal mineralocorticoid receptor (MR) antagonists have… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2019
2019
This was a phase 2, multicenter, randomized, double-blind, placebo-controlled, open-label comparator study to investigate the… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 5
Is this relevant?
2019
2019
Esaxerenone (CS-3150) is a novel, nonsteroidal, selective mineralocorticoid receptor blocker. The absorption, metabolism… Expand
Is this relevant?
2018
2018
Herein, we studied the effects of the novel nonsteroidal selective mineralocorticoid receptor (MR) blocker, esaxerenone, on blood… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2017
2017
Abstract 1. Esaxerenone (CS-3150) is a novel non-steroidal mineralocorticoid receptor antagonist. The pharmacokinetics, tissue… Expand
Is this relevant?
2016
2016
The present study was designed to assess both preventive and therapeutic effects of (S)-1-(2-Hydroxyethyl)-4-methyl-N-[4… Expand
Is this relevant?
2015
2015
The present study was designed to evaluate the antihypertensive and cardiorenal protective effects of CS-3150, a novel non… Expand
Is this relevant?
2015
2015
The present study was designed to characterize the pharmacological profile of CS-3150, a novel non-steroidal mineralocorticoid… Expand
Is this relevant?